Please note that the ANZCTR website will be unavailable from 9am until 9.30am (AEST) on Monday 22nd July for website maintenance. Please be sure to log out of the system in order to avoid any loss of data. Thank you and apologies for any inconvenience caused.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12608000501347
Ethics application status
Approved
Date submitted
13/08/2008
Date registered
30/09/2008
Date last updated
23/10/2013
Type of registration
Prospectively registered

Titles & IDs
Public title
Prophylactic Antibiotics for spontaneous prelabor rupture of membranes at term
Scientific title
Prophylactic antibiotics for spontaneous prelabor rupture of membranes at term to reduce early neonatal sepsis
Secondary ID [1] 262226 0
ASU2010
Universal Trial Number (UTN)
U1111-1122-0540
Trial acronym
PAST PROM
Linked study record

Health condition
Health condition(s) or problem(s) studied:
prelabor rupture of membranes at term 3550 0
Condition category
Condition code
Reproductive Health and Childbirth 3706 3706 0 0
Childbirth and postnatal care

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
prophylactic antibiotics
ampicillin/flucloxacillin
500 mg intravenously every 6 hours
started on admission till delivery
Intervention code [1] 3263 0
Prevention
Comparator / control treatment
The solvent of the antibiotic vial every 6 hours from admission till delivery
Control group
Placebo

Outcomes
Primary outcome [1] 4610 0
early neonatal sepsis diagnosed clinically and by laboratory markers of sepsis
Timepoint [1] 4610 0
at 1 week after randomisaton
Secondary outcome [1] 7779 0
maternal postpartum febrile morbidity diagnosed clinically
Timepoint [1] 7779 0
at 2 weeks after randomisation

Eligibility
Key inclusion criteria
spontaneous rupture of fetal membranes at 36 weeks gestation or beyond
Minimum age
No limit
Maximum age
No limit
Gender
Females
Can healthy volunteers participate?
No
Key exclusion criteria
chorioamnionitis
prolonged rupture of membranes >24

Study design
Purpose of the study
Prevention
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation concealment: opaque sealed envelopes
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
computerized sequence generation
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint(s)
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment outside Australia
Country [1] 1152 0
Egypt
State/province [1] 1152 0

Funding & Sponsors
Funding source category [1] 3729 0
University
Name [1] 3729 0
Ain Shams University
Address [1] 3729 0
Ramses street
Abbassia,
Cairo
Country [1] 3729 0
Egypt
Primary sponsor type
Individual
Name
Ashraf Nabhan
Address
50, Al-Khalifa Al-Mamoun street,
Roxi
Country
Egypt
Secondary sponsor category [1] 3346 0
Individual
Name [1] 3346 0
Amr El-Helaly
Address [1] 3346 0
Department of Obstetrics and Gynecology, Ain Shams University
Country [1] 3346 0
Egypt
Other collaborator category [1] 277663 0
Individual
Name [1] 277663 0
M Elkady
Doaa Ahmed
Address [1] 277663 0
Department of Obstetrics and Gynecology, Ain Shams University, Cairo 11341, Egypt
Country [1] 277663 0
Egypt

Ethics approval
Ethics application status
Approved

Summary
Brief summary
The study will investigate the value of prescribing antibiotics for women who have a rupture of fetal membranes before labor at term. There is still a gap in our knowledge regarding the best practice for women with prelabor rupture of membranes at term
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 28838 0
Prof Ashraf nabhan
Address 28838 0
Department of Obstetrics and Gynecology, Ain Shams University, Cairo 11341, Egypt
Country 28838 0
Egypt
Phone 28838 0
+20222595775
Fax 28838 0
Email 28838 0
anabhan@med.asu.edu.eg
Contact person for public queries
Name 11995 0
Prof Ashraf Nabhan
Address 11995 0
50, Al-Khalifa Al-Mamoun street,
Roxi
Country 11995 0
Egypt
Phone 11995 0
+20222595775
Fax 11995 0
Email 11995 0
ashraf.nabhan@gmail.com
Contact person for scientific queries
Name 2923 0
Prof Ashraf Nabhan
Address 2923 0
50, Al-Khalifa Al-Mamoun street,
Roxi
Country 2923 0
Egypt
Phone 2923 0
+20222595775
Fax 2923 0
Email 2923 0
ashraf.nabhan@gmail.com

No information has been provided regarding IPD availability
Summary results
Have study results been published in a peer-reviewed journal?
Other publications
Have study results been made publicly available in another format?
Results – basic reporting
Results – plain English summary